{"id":11349,"date":"2025-07-26T23:27:26","date_gmt":"2025-07-26T21:27:26","guid":{"rendered":"https:\/\/valintermed.com\/?p=11349"},"modified":"2025-07-26T23:27:26","modified_gmt":"2025-07-26T21:27:26","slug":"gestatsionnaya-trofoblasticheskaya-bolezn","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/gestational-trophoblastic-disease\/","title":{"rendered":"Gestational trophoblastic disease"},"content":{"rendered":"
<\/div>\n

Gestational trophoblastic disease (GTD) is a rare group of neoplastic diseases that arise from the trophoblast cells that form the placenta during pregnancy. This pathological process can manifest itself in different forms, the most well-known of which is the hydatid form, or molar pregnancy. GTD can occur against the background of a normal pregnancy or as a consequence of pregnancy failure. The disease is characterized by abnormal proliferation of trophoblastic cells, which can lead to the formation of tumors, both benign and malignant, and is accompanied by various clinical manifestations, including bleeding, increased levels of human chorionic gonadotropin (hCG), and reproductive system disorders. It is important to note that GTD requires careful diagnosis and monitoring, since in some cases it can lead to serious complications, including tumor metastasis.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n